Header
SABPA Newsletter, June 2017
In This Issue
Connect With Us
 
Subscribe to our WeChat 

SABPA Events

16th San Diego BioPharma Conference and SABPA Bio-Partnering (Jun. 17th)

When:  Jun 17, 2017 8:00am-5:00pm
Where: Hilton Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CA 92014
Registration:
$40 for general admission ($80 onsite)
$30 for postdocs/students ($60 onsite)
$100 1-on-1 Bio-Partnering with complimentary general admission     (registration closes on Jun 13th, 2017)
Registration link:
San Diego BioPharma Conference, the flagship event of SABPA, has witnessed the boom of the pharmaceuticals and biotechnology industry in one of the nation’s premier innovation centers. This annual conference has been featuring some of the most respectful figures in the fields, from potential Nobel laureates and technologically disruptive inventors, to entrepreneurs and multi-billion-dollar dealmakers. This year, we will also be celebrating the 15th anniversary of SABPA, which has become one of the most influential organizations in our industry in Southern California. Come and meet some of the visionary leaders and to network with your peers.  Topics include the cutting-edge research on Immuno-Oncology, disruptive technologies, creative business models and strategies to succeed in the ever-changing global market.  This is one of the biggest San Diego biotech events that you don’t want to miss.

2017 San Diego BioPharma Achievement Award Recipient

J. Craig Venter, Ph.D.
Co-Founder and Executive Chairman – Human Longevity, Inc. (HLI)
Founder, Chairman and CEO – J. Craig Venter Institute (JCVI)
Co-Founder, CEO and CSO – Synthetic Genomics, Inc.
Confirmed speakers:
K. Barry Sharpless, Ph.D. W. M. Keck Professor of Chemistry, TSRI
Richard Geary, Ph.D., Sr. VP, Development, Ionis Pharmaceuticals
Jeffrey Staford, Ph.D. CEO & Founder, Jecure Therapeutics, Inc
Ming Guo, Ph.D. President & COO Ascentage Pharma
Joe Panetta, MPH President & CEO, Biocom – The Life Science Association of CA
Robert Popovian, Pharm. D. VP of US Government Relations, Pfizer
Greg Scott, Founder, ChinaBio Group
Peng Chen, JD, Ph.D., Partner, MoFo
Tong-Tong Xue, PhD CEO, Kelun-Biotech Biopharmaceutical Company and VP, Kelun Pharmaceutical Research Institute 
Panel Discussion: BioPharma Outlook in the New Global Environment
 
Confirmed panelist:
Joe Panetta, MPH, President & CEO, Biocom – The Life Science Association of CA
Robert Popovian, Pharm. D. VP of US Government Relations, Pfizer
Lisa Haile, Ph.D., J.D. Partner & Co-Chair, Global Life Sciences Sector, DLA Piper
Daniel Kleeburg, Partner, Ernst & Young

Ming Guo, Ph.D. President & COO Ascentage Pharma
Greg Scott, Founder, ChinaBio Group

 
SABPA Bio-Partnering
Hosted together with BioPharma Conference
Hilton Del Mar, June 17, 2017
Co-Organizers: SABPA, ChinaBio
 
SABPA Bio-Partnering is a great platform to explore the opportunities of licensing, investment, fund raising, procurement and other collaboration deals.  It is designed for you to pre-arrange 1-on-1 face-to-face meetings with potential partners/investors by using the online tool Partnering360*.  Participants can upload their profile to the platform, send invitations to other participants.   Once the invitations are accepted, the 30min private meetings will be arranged automatically.   Participants have access to pre-scheduled 1-on-1 meetings in designated meeting areas during the conference, as well as access to Partnering360* database all year round.  Bio-Partnering will be hosted at the same time and in the same venue with San Diego BioPharma Conference (06/17/2017). See the link below for more details.
Who shall attend?
  • Entrepreneurs and executives from local biotech and pharmaceutical companies
  • Chinese pharmaceutical companies who are looking for collaboration opportunities
  • Investors from local firms or cross Pacific
  • Biotech or pharmaceutical service providers
How to Participate?
  • Receive a private Partnering360* event registration link sent by Whova after you complete your registration.
  • Access Partnering360 to enter your profile and schedule meetings. Step-by-step instruction is available here: http://www.sabpa.org/1on1instruction2017/
  • Check your Partnering360 account regularly for responses to your meeting scheduling
  • Act early to allow enough time to pre-arrange meetings ( >2 weeks prior to the event date)
Need Help? For more information, please email: bio-1on1@sabpa.org
Current and Previous Participating Organizations
Investors
  • GF-Bay City Capital International Life Sciences USD Fund
  • Qiming US Healthcare Venture Fund
  • Illumina Ventures
  • Alley Bridge Group
  • HuaQi Capital
  • Proxima Ventures
Companies
  • Abbvie
  • Eli Lilly
  • Denovo Biopharma
  • Theragene Therapeutics
  • Kelun Pharma
  • CTTQ Pharma
  • Simcere
  • Califia Bio
Incubators
  • 中山市健康科技产业基地发展有限公司
  • Sino-Singapore (Chengdu) Innovation Park Development Co
  • Songshan Lake
  • TEDA

Partnering 360 is a third party (EBD Group) online software used to schedule meetings for SABPA Bio-Partnering.

Community Events

USP WCDG & AOAC-SCS Joint Two-Day Regulatory & Compliance Conference, “Critical Regulatory and Compliance Issues with the US FDA in the 21st Century”
When: Thursday, June 15, and on Friday, June 16, 2017
Where: Orange County Water District, Conference Room No. L1, 18700 Ward Street, Fountain Valley, CA
Registration: http://www.aoac-scs.org/2017-spring-conf.html (Breakfast and lunch are included)
Early prepaid registration (received by Friday, June 02, 2017) is $ 10.00 less except for students & FDA Employees. REGISTRATION FOR FIRST TWO STUDENTS IS FREE! (Current Students interested in attending this conference must email their proof in the form of a Student ID or an Official Letter along with their Registration Forms) If you have questions regarding conference registration, please contact: Gina Zhang, E-mail: gina.zhang@medtronic.com
 
USP Western Compendial Discussion Group (WCDG) – AOAC Southern California Section (SCS) kindly offer SABPA members the same registration rates as the AOAC SCS member (please make a note that you are a SABPA member when registering and/or checking in) 
 
Event Summary: This conference will be focused on Current Critical Issues on Pharmaceuticals & Biologics with speakers from the US FDA, USP and industry.
Draft Agenda 
DAY 1 – Thursday, June 15, 2017
KEYNOTE SPEAKER: Lokesh Bhattacharya, Ph.D.
Chief, US FDA, CBER, OCBQ/DBSQC/LACBRP, Silver Spring, MD
TOPIC: Validation of Analytical Methods for Biological Products – In Light of a CBER Reviewer’s Experience
Gurpreet Gill-Sangha, Ph.D.
Acting Quality Assessment Lead (QAL), US FDA, OMPT/CDER/OPQ/OLDP/DPMAI/PMBII, Silver Spring, MD
TOPIC: Lifecycle Management of NDAs – Approaches and Expectations
Mr. Michael Shelton,
Technical Director, Exova Inc., Santa Fe Springs, CA
TOPIC: Plastic Containers and Extractable/Leachable
Dilip Choudhury, Ph.D.
Pharmaceutical Consultant & Former VP, Analytical Sciences, Allergan, Union City, CA
TOPIC: Quality Related Issues in Pharmaceuticals
DAY 2 – Friday, June 16, 2017
KEYNOTE SPEAKER: Laxma Nagavelli, Ph.D.
US FDA, CDER, OPQ/OLDP/DIRPI/IRBIII Office, Silver Spring, MD
TOPIC: Product/Process understanding for Quality Drug Products-Case Studies
Steven Kuwahara, Ph.D.
GXP BioTechnology, Tucson, AZ
TOPIC: Data Integrity in the Laboratory
Steven Kuwahara, Ph.D.
GXP BioTechnology, Tucson, AZ
TOPIC: Data Integrity Deficiencies & Warning Letters – Case Studies
Mark Alsandro, Ph.D.
Orexigen Therapeutics, La Jolla, CA
TOPIC: Enhancing Pharmaceutical Quality through Predictive Stability Modeling
To register or to learn more about this exciting event, visit: http://www.aoac-scs.org/2017-spring-conf.html
Redefining Early Stage Investments (RESI) San Diego Conference
WHEN:           June 19, 2017 @ 8:00am – 7:00pm
WHERE:         The Westin San Diego Gaslamp Quarter, 910 Broadway Circle, San Diego, CA 92101
INFO              The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital.
REGISTER    Register here (xe68typab&showPage=true)
Use promotion code SABPA for $100 discount.
The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors, create relationships, and close the gap on finding capital. These events give life science companies the chance to start, resume or close conversations with relevant investors, creating a global dialogue to bring products to market at a faster pace. RESI brings qualified investors from ten categories including, Family Offices, Venture Philanthropy, Patient Groups, Corporate Development, Virtual Pharma, Endowments, Foundation, and Angels. The conference helps facilitate face to face meetings between companies and investors based on a common fit (indication, technology & stage of development) which promotes compelling conversations, facilitating the development of qualified investor to entrepreneur relationships. The RESI Conference also serves as an excellent opportunity for large pharma/ medtech companies and service providers to connect with attending companies and investors representing their portfolio companies.
Sponsor: Life Science Nation
Festival of Genomics (FoG) San Diego
                    
The Festival of Genomics (FoG) San Diego is a 2-day celebration of genomics bringing together leaders in academia, biopharma, and healthcare all in one place to explore the recent advancements in the field of genomics. Registration/admission is FREE.
Why should you get involved this year?
The FoG San Diego will present the very best in West Coast genomics, featuring over 70 speakers from:
*       Rady Children’s Hospital
*       Human Longevity, Inc.
*       J. Craig Venter Institute
*       Genentech Inc.
*       Google
*       Stanford University
*       University of California, San Diego
In its third year, the Festival has earned a reputation for innovative experiences, field-defining discussions, and bringing together the who’s who of genomic stakeholders. It is unique in its ability to bring together full cross sections from across academia, biopharma, and healthcare.
Covering four main themes: research and development, precision therapies, enabling data management and personalizing medicine, this year’s Festival has something for everyone.
View the themes and sessions over the two days – www.festivalofgenomicssandiego.com/agenda/2017-agenda
The Festival will highlight the technical excellence in the region through sessions discussing the newest advancements in computational biology, CRISPR, synthetic biology, and single-cell sequencing.
Experience all this for yourself at the San Diego Convention Center on the 26th & 27th of June 2017
Already booked into the exhibition floor offering service and solutions include Beckman Coulter, Bio-Rad, Axio Research, Dolomite Bio, Envision Genomics, Edico Genome, Agilent Technologies, Twist Biosciences, Synthego, NGX Bio, OnRamp Bioinformatics, MilliporeSigma, Biotix, Advanced Analytical Technologies, Metabolon, tevixMD, Zymo Research Corporation, Paragon Genomics, CG Life.
Find out more about them here: www.festivalofgenomicssandiego.com/exhibitors
New additions to the Festival this year:
*  ‘Launch Pad Zone’ dedicated to exciting new start-up companies offering potentially disruptive technologies.
*  ‘Lunch & Learn’ sessions – a series of presentations given by leading genomic organizations and established tech companies in the field.
Are you interested in joining the biggest growing genomics community for free?
20th Annual San Diego MedChem Symposium
                    
When: Friday, July 14, 2017
Where: Hojel Hall, Institute of the Americas
Organized by
Dr. Ben Pratt, Dr. Mark Tichenor, Dr. David Wallace – San Diego Section of the American Chemical Society
Dr. Emmanuel Theodorakis – UCSD Department of Chemistry and Biochemistry
8:30 AM             Registration and Continental Breakfast
9:00                   Opening Remarks:  Emmanuel Theodorakis
9:05                   Dr. Pei-Pei Kung, Pfizer
                          “Use of Ligand- and Property-Based Design Strategies in Medicinal Chemistry.
                                     Identification of an EZH2 Inhibitor Development Candidate”
                              
9:50                   Dr. Keary Engle, The Scripps Research Institute
                          “Programmed Functionalization of Alkenes via Directed Nucleometalation”
10:35                 Coffee Break
10:50                Dr. Paul Sprengeler, eFFECTOR Therapeutics
                         “Identification of eFT508, an Oral, Potent and Highly Selective Inhibitor of Mitogen-Activated Protein Kinase Interacting Kinase (MNK) 1 and 2, via a Disciplined, Iterative Structure-Based Drug Design Strategy”
11:35                 Dr. Yitzhak Tor, University of California San Diego
                          “New Isomorphic Fluorescent Nucleosides for Biophysical and MedChem Applications”
12:20 PM           Lunch
1:20                   Jeff Smith, The Genomics Institute of the Novartis Research Foundation
                          “Proteasome Inhibitors:  A Single Cure for Multiple Kinetoplastid Diseases”
2:05                   Dr. Laurent Gomez,Dart NeuroScience
                          “Discovery of Selective Phosphodiesterase 2 (PDE2a) Inhibitors for the Treatment of Memory Disorders”
2:50                   Symposium Conclusion

To register please visit: http://chemistry.ucsd.edu/go/medchem follow the link to the registration page.

CTIC Capital Healthcare Investment Summit
Date: January 8th, 2018
Location: San Francisco Airport Marriott Waterfront
Conference Introduction: CTIC Capital is committed to create valuable connections for US companies that are interested in raising capital and developing business relationships in China.
Get ready to pitch!
We will bring you Chinese investors (100+) who are actively searching for US investment and business collaboration opportunities.
Get ready to be inspired!
Impressive lineup of investors from US and China to share challenges and opportunities in areas such as: Precision Medicine, Early Drug Development, Medical Devices, Cross Border M&A, Fund Raising and more.
 
Get ready to connect!
Mobile APP would assist you in submitting inquiries of one-on-one investors meetings before and during the conference.
SABPA Member Discount Code (expires 12/10/17): 2017SABPACTIC ($300 off) Only 20 tickets available at this discounted price.
CTIC Capital
CTIC Capital is a Silicon Valley based boutique private equity consulting firm focusing on Internet technology, renewable energy, and healthcare. Leveraging our trans-pacific network and local expertise, CTIC Capital helps enterprises in US and China in funding, M&A, and strategic partnership development.
CTIC has helped many startups and VCs in both US and China in their cross-border investment and business development efforts. Our goal is to be the leader of US-China cross-border investment alliance to companies and VCs.

Our Platinum Corporate Sponsors

Our Gold Corporate Sponsors
About SABPA
Sino-American Biotechnology and Pharmaceutical Professionals Association (SABPA) is an 501(c)(3) nonprofit organization founded in early 2002 by professionals and scholars from the Chinese community in San Diego. In 2005, we expanded to Orange County and Los Angeles. We invite all scholars, professionals and entrepreneurs of any origin who are working in, engaged in, or interested in the biotech and pharmaceutical industry in Southern California to join us as a member of SABPA.
Our Mission
  • Provide a forum to facilitate professional contact and communication among local Chinese American professionals in academia, biotech and pharmaceutical industries;
  • Foster professional growth, career improvement and personal development of our members;
  • Provide opportunities to educate local communities about the values of biomedical research and the benefits of biotech and pharmaceutical innovations;
  • Stimulate and facilitate the development of relationships between the U.S. and China in biotech and pharmaceutical communities.
  • To fulfill our mission, we will sponsor professional seminars, meetings, and symposia; share employment opportunity information in local biotech and pharmaceutical industry; sponsor social events; and disseminate information about local biotech and pharmaceutical companies.
SABPA.org, P.O. BOX 927631, San Diego, CA 92192